Other liabilities

12 Months Ended

Dec. 31, 2022

Other liabilities

Other liabilities

8. Other liabilities

As of December 31, 2022 and 2021, other current and non-current liabilities consisted of the following:

	As of December 31,
	2022		2021
	(in thousands)
Other current liabilities
Lease liabilities		2,832		5,571
Total other current liabilities	$	2,832	$	5,571
Other non-current liabilities
Lease liabilities	$	20,294	$	38,608
Other		1,001		1,001
Total other non-current liabilities	$	21,295	$	39,609

Strategic Restructuring

On August 6, 2021, the board of directors of the Company approved a strategic restructuring plan to eliminate a portion of its workforce as part of an initiative to reduce expenses and enhance operations. The strategic restructuring plan was approved in connection with its portfolio reevaluation efforts and its strategic shift to invest additional resources in the Company’s TRACER capsid development efforts.

During the year ended December 31, 2021, the Company incurred restructuring costs of approximately $2.6 million, which consists of severance-related costs. These costs are reported within our research and development expenses and general and administrative expenses. Substantially all costs have been paid as of December 31, 2022.